Notice: Fall 2017 exams affected by natural disasters... More >

Expand/Collapse Close

ABIM knows that we have many physicians whose lives have been upended by recent natural disasters. If you live or work near an affected area, we understand that the weather may have impacted your ability to take your Fall 2017 exam as scheduled. We have developed a series of options to help you get through this process as smoothly as possible. If you have any questions, please call us at 1-800-441-ABIM (2246) or email request@abim.org.

American Board of Internal Medicine home page

Initial Certification indicates that physicians have met rigorous standards through intensive study, accredited training and evaluation and that they have the clinical judgment, skills and attitudes essential for the delivery of excellent patient care.

MOC is a professionally determined standard that attests that an internist is staying current in knowledge and practice throughout his/her career.

For more than 75 years, Certification by ABIM has stood for the highest standard in internal medicine and its 20 subspecialties.

Pulmonary Disease Board Exam Committee

Lynn T. Tanoue, MD, Chair

Dr. Tanoue, who is board certified in Internal Medicine, Pulmonary Disease and Critical Care Medicine, is Professor of Medicine and Clinical Chief of the Section of Pulmonary, Critical Care, and Sleep Medicine, and Vice-Chair for Clinical Affairs in the Department of Internal Medicine at Yale School of Medicine in New Haven, Connecticut. She co­directs the Yale Thoracic Oncology Program and the Yale Screening and Nodule Program at Smilow Cancer Hospital at Yale-New Haven, and is the principal investigator of the Yale Lung Cancer Biorepository. Her academic focus is in the field of thoracic oncology.

Dr. Tanoue is currently Chair of the American Board of Internal Medicine (ABIM) Pulmonary Disease Board Exam Committee and a member of the ABIM Pulmonary Disease Board. She is Vice-Chair of the American College of Chest Physicians Thoracic Oncology Network Steering Committee. She serves on the program committee for the American Thoracic Society Thoracic (ATS) Oncology section and is a member of the ATS Clinician Practice Council. She is immediate past President of the National Association for Medical Direction of Respiratory Care.

Dr. Tanoue received her bachelor's degree from Harvard University and medical degree from Yale School of Medicine. She did her internal medicine residency, chief residency and a fellowship in pulmonary/critical care medicine at Yale-New Haven Hospital.

As of January 2017, Dr. Tanoue reported the following external relationships:

Work as an author or editor for the following companies, with compensation as listed:

  • UpToDate, receiving compensation for authorship.
  • Elsevier, receiving compensation as an Editor of “Year Book of Pulmonary Disease.”

Dr. Tanoue serves in significant roles with the following healthcare-related organization, receiving reimbursement or compensation as listed:

  • American Thoracic Society, Program Chair, Thoracic Oncology Assembly, without compensation.

Dr. Tanoue serves as a consultant to the Norwalk Hospital Thoracic Tumor Board, receiving honoraria.

Charles W. Atwood Jr., MD

Dr. Atwood is board certified in Pulmonary Disease, Critical Care Medicine and Sleep Medicine. He is an Associate Professor of Medicine at the University of Pittsburgh School of Medicine, and a staff physician at the VA Pittsburgh Healthcare System, where he is the Director of the Sleep Disorders Program, and the University of Pittsburgh Medical Center, where he is the Director of the Sleep Medicine Fellowship.

Dr. Atwood is a member of the American Board of Internal Medicine Pulmonary Disease Board Exam Committee. He has been active in a variety of professional societies including the American Thoracic Society, the American College of Chest Physicians (where he was the founding Chair of the Sleep Institute), the American Academy of Sleep Medicine and the National Association for Medical Direction of Respiratory Care. His research interests focus on improving access and quality of care for patients with sleep apnea.

Dr. Atwood received a bachelor's degree in English from Sewanee: The University of South. He earned his medical degree and completed a medical residency at the University of Alabama School of Medicine and then completed pulmonary, critical care and sleep medicine training at the University of Pittsburgh.

As of April 2017, Dr. Atwood reported the following external relationships:

Dr. Atwood serves in significant roles with the following healthcare-related organization, receiving reimbursement or compensation as listed:

  • National Association for the Medical Direction of Respiratory Care, President-Elect for the Board of Directors and as a member of the Executive Committee, without compensation.

David H. Au, MD

Dr. Au is Professor of Medicine at the University of Washington and Director of the Center of Innovation for Veteran-Centered and Value-Driven Care at the VA Puget Sound Health Care System. His work focuses on improving delivery, quality and value of care for patients with chronic lung disease and other complex chronic conditions. In particular, Dr. Au has expertise in interventions targeting the health care system and providers with the goal of improving patient-centered outcomes. He is supported through a number of federal agencies including the Department of Veterans Affairs; the National Heart, Lung and Blood Institute; and the Centers for Disease Control. Dr. Au is board certified in both Pulmonary Disease and Critical Care Medicine.

Dr. Au is a member of the American Board of Internal Medicine Pulmonary Disease Board Exam Committee. He chairs the Respiratory Measurement Advisory Panel for the National Committee for Quality Assurance. He has held a number of positions within the American Thoracic Society (ATS), including Chair of the International Conference Committee, Behavioral Science and Health Services Research Assembly, and was a member of the ATS Board of Directors. He is a recipient of the Assembly on Behavioral Science and Health Services Research Lifetime Achievement Award. Dr. Au is an active research mentor and is co-Director of the University of Washington Clinical Research Track.

Dr. Au earned both his undergraduate and medical degrees at the University of Chicago, the latter at the Pritzker School of Medicine. He received a master's degree in epidemiology from the University of Washington. Dr. Au completed residency training in internal medicine at the University Hospitals of Cleveland, and Pulmonary and Critical Care Fellowships at the University of Washington. He also completed a health services research and development fellowship at the VA Puget Sound Health Care System.

As of January 2017, Dr. Au reported the following external relationships:

Service on data and safety monitoring boards for the following company, with compensation for travel expenses and honoraria:

  • Novartis

Grant funding from other not-for-profit healthcare-related organizations for staff, paid to the University of Washington:

  • American Lung Association, co-investigator for Airways Clinical Research Centers.

Joseph M. Forrester, MD

Dr. Forrester is President of Critical Care and Pulmonary Consultants, P.C. He has held this position, overseeing the pulmonary, critical care and internal medicine hospital care provided at the hospitals serviced by Critical Care and Pulmonary Consultants since 1995. The 85-physician practice provides outpatient and inpatient pulmonary and sleep services, inpatient critical care services, and hospitalist services to five hospitals in the Denver, Colorado metropolitan area. Dr. Forrester is also Director and Director of Hospitalist Services of the Intensive Care Unit at The Medical Center of Aurora.

Dr. Forrester served four years as a physician in the United States Navy, with two years at Bethesda Naval Hospital and the Uniformed Services Medical School. He is a Fellow of the American College of Physicians and the American College of Chest Physicians.

Dr. Forrester is a member of the American Board of Internal Medicine Pulmonary Disease Board Exam Committee. He is board certified in Internal Medicine, Pulmonary Disease, Critical Care Medicine and Sleep Medicine.

He earned a degree in chemistry from Kalamazoo College and a medical degree with high distinction from Wayne State University. Dr. Forrester completed his internal medicine house staff training and chief residency at The University of Michigan Hospitals and his pulmonary and critical care training at the University of Colorado Health Science Center.

As of January 2017, Dr. Forrester reported no external relationships.

Nizar N. Jarjour, MD

Dr. Jarjour, who is board certified in Internal Medicine, Pulmonary Disease and Critical Care Medicine, is a Professor of Medicine and head of the Division of Allergy, Pulmonary and Critical Care Medicine at the University of Wisconsin School of Medicine and Public Health in Madison, Wisconsin. He leads an integrated translational research program that involves human studies of asthma mechanisms and therapy. The role of eosinophils in allergic airway inflammation and remodeling has been a long-standing interest and a focus for his laboratory for over two decades.

Dr. Jarjour is the Principal Investigator of a program project grant focused on the role of the eosinophils in allergic asthma and leads another research project that is part of the National Institutes of Health funded Severe Asthma Research Program. His research has led to more than 125 peer-reviewed papers over the past two decades, most recently averaging more than 800 citations annually. In addition, Dr. Jarjour is very involved in providing professional service at the national level, most recently as a member of the Federal Drug Administration Pulmonary and Allergy Drug Advisory Committee.

He is an active clinician, practicing pulmonary and critical care medicine and directing the Clinical Research Unit at University of Wisconsin Institute for Clinical and Translational Research. He is a member of the American Board of Internal Medicine Pulmonary Disease Board Exam Committee and has been consistently named one of the “Top Docs” in the Madison area and “Best Doctors in America”.

After graduating from Damascus University in Syria in 1980, Dr. Jarjour completed his internal medicine residency at Cook County Hospital in Chicago, Illinois in 1986 and a pulmonary/critical care fellowship at the University of Wisconsin, Madison, Wisconsin in 1990 before joining the faculty there, rising through the ranks to Professor and Division Head in 2004.

As of April 2017, Dr. Jarjour reported the following external relationship:

Dr. Jarjour is president of the University of Wisconsin Medical Foundation.

Francis X. McCormack, MD

Dr. McCormack, who is board certified in Internal Medicine and Pulmonary Medicine, is Taylor Professor and Director of the Division of Pulmonary, Critical Care and Sleep Medicine at the University of Cincinnati School of Medicine. There, he leads a group of 35 faculty members who care for patients with critical illness, lung cancer, pulmonary hypertension, cystic fibrosis, asthma, chronic obstructive pulmonary disease and interstitial lung diseases. He has an active outpatient and inpatient consultative practice. Dr. McCormack also conducts multicenter, international, investigator-initiated trials, and directs a National Institutes of Health (NIH) funded basic research program focused on the role of the alveolar epithelium in innate immunity, pulmonary fibrosis and rare lung diseases.

Dr. McCormack is a member of the American Board of Internal Medicine Pulmonary Disease Board Exam Committee. He has served on study sections and committee for the NIH, the Food and Drug Administration, the Department of Veteran Affairs, the Department of Defense, the American Lung Association and the American Thoracic Society. He is a member of the Alpha Omega Alpha Honor Medical Society and the American Society for Clinical Investigation.

Dr. McCormack received a chemistry degree from the University of California, San Diego and his medical degree from the University of Texas Medical Branch. He completed house staff training in internal medicine at the University of Michigan, and was a Chief Resident there. He received training in pulmonary and critical care medicine at the University of Colorado and was on faculty there for four years before moving to Cincinnati.

As of January 2017, Dr. McCormack reported the following external relationships:

Service on data and safety monitoring boards for the following companies, with compensation as listed:

  • Takeda Pharmaceutical Co., to oversee a study of namilumab, an antibody against granulocyte macrophage colony-stimulating factor, for psoriasis and rheumatoid arthritis, receiving reimbursement for travel expenses and honoraria.

Consulting on design of new drugs or devices, clinical trials, the use of specific agents or other research-related activities for the following companies, with compensation as listed:

  • LAM Therapeutics, advising on potential treatments for lymphangioleiomyomatosis, with hourly compensation paid to the University of Cincinnati.

Post-marketing clinical research, with funding for staff provided to University of Cincinnati, from the following company:

  • Merck, for a clinical trial of a drug for pulmonary fibrosis.

Work as an author or editor for following companies, with compensation as listed:

  • Springer, receiving royalties for textbook chapters.
  • UpToDate, receiving compensation for authorship.

Dr. McCormack holds a patent for a diagnostic test for lymphangioleiomyomatosis, licensed to Vegenics, with royalty income paid to the University of Cincinnati.

Dr. McCormack serves in significant roles with the following organizations, receiving reimbursement or compensation as listed:

  • The LAM Foundation, Scientific Director, receiving reimbursement for travel expenses, paid to the University of Cincinnati.
  • Tuberous Sclerosis Alliance, Medical Advisory Board, receiving reimbursement for travel expenses, paid to the University of Cincinnati.

David E. Ost, MD

Dr. Ost is Professor of Medicine at The University of Texas MD Anderson Cancer Center. He is board certified in Pulmonary Disease and Critical Care Medicine. He is Director of Clinical Research in the Department of Pulmonary Medicine.

Dr. Ost joined the Department of Pulmonary Medicine at MD Anderson Cancer Center in 2008. Prior to this he was an Associate Professor at New York University School of Medicine in the Division of Pulmonary and Critical Care Medicine and Director of Interventional Pulmonology from 2005 to 2008. From 1996 to 2005, he was Director of Interventional Pulmonology at North Shore-Long Island Jewish Medical Center.

Dr. Ost is a member of the American Board of Internal Medicine Pulmonary Disease Board Exam Committee. He has served on the Board of Directors of the American Association for Bronchology and Interventional Pulmonology. He was awarded the Pasquale Ciaglia Memorial Award in Interventional Pulmonology in 2013. He is an associate editor for the Journal of Bronchology and Interventional Pulmonology and the Annals of the American Thoracic Society. He was winner of the Alfred Sofer award in 2006.

Dr. Ost graduated from the Pennsylvania State University with a bachelor's degree in science in 1986. He graduated from Jefferson Medical College in 1990. He completed an internship and residency in Internal medicine at Northwestern University in 1993. He completed a fellowship in pulmonary and critical care medicine at Northwestern University in 1996. He also has a master's degree in public health from the Harvard School of Public Health.

As of January 2017, Dr. Ost reported the following external relationships:

Funding for clinical trial expenses from the following company:

  • Fresh Medical Laboratories, serving as the site principal investigator for a clinical trial of a tool for early detection of lung cancer as an adjunct to lung CT in the evaluation of patients with pulmonary lesions suspicious for lung cancer.

Service on a research-related expert panel or advisory board for the following company, with compensation for honoraria:

  • Vida, for looking at CT imaging data sets to do volumetric measurement of lung nodules and precision imaging for lung cancer surgery.

Work funded by educational grants from industry for staff, paid to MD Anderson Cancer Center, from the following company:

  • Pulmotect, for research on pneumonia in parainfluenza virus.

Work as an author or editor for following company, with compensation as listed:

  • UpToDate, receiving compensation for authorship.

Mindy S. Shapiro, MD

Dr. Shapiro is the Medical Director of the Intensive Care Unit of Kaiser Permanente Santa Rosa Medical Center, Santa Rosa, California, and a practicing pulmonologist in The Physicians Medical Group of Northern California. She is board certified in Internal Medicine, Pulmonary Medicine and Critical Care Medicine.

Dr. Shapiro is a member of the American Board of Internal Medicine Pulmonary Disease Board Exam Committee. She has served on the Medical Executive Committees of Sunrise Hospital and Desert Springs Hospital Medical Center in Las Vegas, Nevada. She was the founding Medical Director of IntensiCare Corporation, a hospitalist company based in San Diego, California.

Dr. Shapiro received a bachelor's degree in biology from Radcliffe College, Harvard University. She received her medical degree from Johns Hopkins University School of Medicine. She was a member of the Osler Medical Housestaff Program of the Johns Hopkins Hospital, and she completed her pulmonary and critical care fellowship at Yale University Hospitals.

As of January 2017, Dr. Shapiro reported no external relationships.

Peter H. S. Sporn, MD

Dr. Sporn, a board certified internist, pulmonologist and critical care specialist, is Professor of Medicine and Cell and Molecular Biology at the Feinberg School of Medicine of Northwestern University. He is Program Director of the Northwestern University Pulmonary and Critical Care Fellowship Program, a position he has held since 1996, and since which time he has directed the training of 75 pulmonary and critical fellows.

Since 2010, Dr. Sporn has been a member of the American Board of Internal Medicine Pulmonary Disease Board Exam Committee. His clinical interests include asthma, chronic obstructive pulmonary disease, eosinophilic respiratory diseases, interstitial lung diseases and sarcoidosis. His research interests include the role of eicosanoids in lung inflammation, eosinophil biology, mechanosignaling in lung injury and repair, innate immunity and lung host defense. He has been supported by the National Institutes of Health and the Department of Veterans Affairs throughout his research career.

Dr. Sporn received his undergraduate degree from the University of Chicago and his medical degree from Wayne State University School of Medicine. He trained in internal medicine at Bronx Municipal Hospital Center (now Jacobi Medical Center)/Albert Einstein College of Medicine and in pulmonary and critical medicine at the University of Michigan.

As of January 2017, Dr. Sporn reported the following external relationships:

Work as an author or editor for the following company, with compensation as listed:

  • McGraw-Hill, receiving compensation for authorship of a chapter in Fishman's Pulmonary Diseases and Disorders, Fifth Edition.

James K. Stoller, MD, MS

Dr. Stoller is a pulmonary/critical care physician and Chairman of the Education Institute at the Cleveland Clinic in Ohio. He also serves as a member of the Respiratory Institute at the Cleveland Clinic, where he served previously as the Vice Chairman of Medicine, Head of the Section of Respiratory Therapy, and as Executive Director of Physician Leadership Development. He holds the Jean Wall Bennett Professorship of Medicine at the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University and the Samson Global Leadership Academy Endowed Chair and has a secondary appointment as Professor of Organizational Behavior in the Weatherhead School of Management of Case Western Reserve University.

Dr. Stoller’s current clinical research interests focus on chronic obstructive pulmonary disease and especially alpha-1 antitrypsin deficiency and on strategies of care delivery, especially regarding respiratory therapy. He serves as a reviewer and contributor to a number of national and international publications and has authored and edited numerous books, chapters, original peer-reviewed reports, and abstracts.

He currently serves as an Associate Editor for Respiratory Care, as a member of the editorial boards of Clinical Pulmonary Medicine and of Thorax. Dr. Stoller is a Trustee of the American Respiratory Care Foundation and a member of the Board of Directors of the Alpha 1-Foundation. He is also a member of the American Board of Internal Medicine Pulmonary Disease Board Exam Committee. He is a Fellow of the American College of Physicians, the American College of Chest Physicians, and the American Association for Respiratory Care.

Dr. Stoller holds a medical degree from Yale University School of Medicine. He completed residency at Peter Bent Brigham Hospital in Boston, Massachusetts and a fellowship in pulmonary medicine at Brigham and Women's Hospital. He also completed a pulmonary medicine fellowship at Yale University School of Medicine and served as a Robert Wood Johnson Clinical Scholar in clinical epidemiology. Additionally, Dr. Stoller completed a fellowship in critical care medicine at the Massachusetts General Hospital. He holds a master's degree in organizational development and analysis from the Weatherhead School of Management at Case Western Reserve University. He is board certified in Internal Medicine, Pulmonary Disease and Critical Care Medicine.

As of May 2017, Dr. Stoller reported the following external relationships:

Service on data and safety monitoring boards for the following companies, with compensation for travel expenses and honoraria:

  • Shire, for a trial of augmentation therapy for alpha-1 antitrypsin.
  • CSL Behring, for a trial of a drug for augmentation therapy of alpha-1 antitrypsin deficiency.
  • Grifols, for a trial of augmentation therapy for alpha-1 antitrypsin deficiency.

Consulting on design of new drugs or devices, clinical trials, the use of specific agents or other research-related activities for the following company, with compensation for travel expenses and honoraria:

  • Arrowhead, for consulting regarding RNA interference for treatment of alpha-1 antitrypsin deficiency.

Work as an author or editor for following companies, with compensation as listed:

  • Elsevier, receiving compensation as an editor for the book, “Egan's Fundamentals of Respiratory Care.”
  • UpToDate, receiving compensation as an editor and author for the COPD section.

Dr. Stoller serves in significant roles with the following organizations, receiving reimbursement for travel as listed:

  • Alpha-1 Foundation, Board of Directors, Medical and Scientific Advisory Committee, receiving reimbursement for travel expenses.
  • American College of Chest Physicians, Education Committee Member, receiving reimbursement for travel expenses.
  • American Respiratory Care Foundation, Board of Directors, receiving reimbursement for travel expenses.
  • COPD Foundation, Medical and Scientific Advisory Committee, receiving reimbursement for travel expenses.

Funding for clinical trial expenses and staff, paid to the Cleveland Clinic, from the following companies:

  • Accreditation Council on Graduate Medical Education, for the Pursuing Excellence Grant to help optimize graduate medical education.
  • American Thoracic Society, for a grant to develop leadership course for American Thoracic Society members.
  • The Doctors Company Foundation, for a grant to extend training to chief residents.
  • CSL Behring, for a trial regarding the consequences of delayed diagnosis of alpha-1 antitrypsin deficiency.
  • National Heart, Lungs, and Blood Institute, for participation in several multicenter trials (Alpha-1 Registry, National Emphysema Treatment Trial, Long-Term Oxygen Treatment Trial).
  • Alpha-1 Foundation, for various studies regarding alpha-1 antitrypsin deficiency.

Dr. Stoller also reported that he has performed phone consultations on various topics in pulmonary medicine organized by Guidepoint Global and by GLG.